Cutaneous adverse events are common in patients taking EGFR inhibitors. Might tetracyclines offer prophylactic or symptomatic treatment?The British Journal of Dermatology http://ift.tt/2k5jXbL
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου